AgingResearch.News
bioRxiv

HER2 mutation-derived neoantigens in NSCLC as actionable targets for TCR therapy

By Amanda Montoya, Hui Nie, Peixin Jiang, Show 21 more authorsAlexandre Reuben
Preprint: experiments in cellsInterventions
Paper

The paper

Amanda Montoya, Hui Nie, Peixin Jiang, Show 21 more authorsAlexandre Reuben

Department of Thoracic/Head & Neck Medical Oncology

bioRxiv, 4 Aug 2026, CC BY-NC-ND, Preprint, not peer-reviewed

doi.org/10.64898/2026.07.30.741830

More in Interventions